The (AGA) is proud to announce the selection of 74 recipients to receive $2.4 million in research funding through the annual ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Allogene Therapeutics, Inc.’s ALLO share price has surged by 5.28%, which has investors questioning if this is right time to ...

More information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Targeted small molecule ...

Another study found that people who had high levels of vitamin D in their diet had a 25% lower risk of developing colorectal ...

The Trump administration has singled out Ivy League universities for funding cuts, but the spending reductions go much ...

Pope Francis passed away at 88 in Rome on Easter Monday after a prolonged illness. The Vatican reported the cause of death as a stroke leading to coma ...

Conference attendees will get first look at new data that supports the potential of ERNA-101 to boost anti-tumor immunity in ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...

CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next ...

Monitoring and analyzing gut microbes may help predict how myeloma patients will respond to CAR T-cell therapy, research ...